Primary study · included by 1 review

Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with [177Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer.

Alan-Selcuk 2023 · Alan-Selcuk Nalan, Beydagi Gamze, Demirci Emre, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.

Non-Cochrane · intervention · 2026 · cited as Alan-Selcuk 2023 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.